Want to join the conversation?
$CAH said it expects its Pharmaceutical segment profit to decline on less year-over-year incremental contribution from its generics program. Another factor is a previously mentioned Pharmaceutical Distribution large customer loss, the impacts of which will continue through the third quarter of fiscal year 2017, the company said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?